Diagnosis

Erythema nodosum

Inflammation of the subcutaneous fat (panniculitis) characterized by painful erythematous, solid, deep nodules or plaques usually affecting the legs.

Etiology

Cause [sc3][qfm]

  1. Idiopathic (55%)

  2. Infection (28-48%): 

    • Bacterial: Streptococcal pharyngitis, Yersinia spp., mycoplasma pneumonia, chlamydia, histoplasmosis, coccidioidomycosis, mycobacteria, Tuberculosis, Leprosy, Tularemia, Cat scratch disease (Bartonella species), Leptospirosis, Brucellosis, Psittacosis, Chlamydia trachomatous, Lymphogranuloma venereum, Campylobacter spp., rickettsiae, Salmonella spp., psittacosis, syphilis

    • Virus: herpes simplex virus, Epstein-Barr Virus (mononucleosis), hepatitis B/C, human immunodeficiency virus, Para vaccinia

    • Fungal: Coccidioidomycosis, Histoplasmosis, Blastomycosis

    • Parasitic: amoebiasis, giardiasis

  3. Systemic disease: Sarcoidosis (11-25%), Ulcerative colitis, Crohns disease, Behcets disease, Sjogren disease, Celiac disease, Autoimmune hepatitis, Spondiloarthropathy, Kawasaki, Takayasu, Blau Syndrome, CAPS, HIDS, Sweet syndrome, Carcinoid, Sarcoma, Whipple disease

  4. Drugs (3-10%): Sulphonamides, amoxicillin, Macrolides, Cephalosporin, PPI, Everolimus, Aspirin, Contraceptives, Azathioprine, Phenitoin, Valproate, bromides, iodides, TNF-alpha inhibitor

  5. Pregnancy (2-5%)

  6. Malignancy: Leukemia, Lymphoma, Occult malignancies

  7. Vaccination: BCG, DTaP, HPV, SARS-CoV-2

Pathophysiology [sc3][qfm]

  1. A cutaneous type IV delayed hypersensitivity reaction to various antigens

  2. Deposition of immune complexes in the venules of subcutaneous fat

  3. Oxygen free radicals + TNF-alpha --> granuloma formation

Epidemiology

Incidence per 100.000 [ben][ozw]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Arthralgia, Arthritis, Fever, Malaise

Clinical findings

None listed.

Anamneses

None listed.

Localized findings

Rash
Radiates
ArmLower body
Distribution
AsymmetricLocalizedMultipleSingleSymmetric
Lesion type
ErythemaNodule
Color
Red
Associated symptom
Pain
Palpation
BlanchingPainWarmth

Approach

Treatment

Painful but self-limited disease lasting 3–6 weeks. Supportive therapy, including bed rest and avoidance of contact irritation of affected areas [sc3]

  1. Treatment of the underlying disorder

  2. Pain --> NSAIDs

  3. Systemic steroids (1 mg/kg) may be used until resolution if underlying infection and malignancy have been excluded

  4. Colchicine if coexistent Behçet's syndrome

  5. Other agents: [yft]

    • Intra-lesional corticosteroid

    • Dapsone

    • Hydroxychloroquine

    • Anti-TNF monoclonal antibodies

    • Thalidomide

    • Methotrexate

Differential diagnoses

Alpha1-antitrypsin deficiency, Behcet's disease, Cellulitis, Crohn disease, Erysipelas, Erythema induratum, Familial mediterranean fever, Fat necrosis, Fracture, Insect Bite, Leukemia, Lymphoma, Phlebitis, Sarcoidosis, Scleroderma, Systemic lupus erythematosus, Thrombophlebitis, Ulcerative colitis, Urticaria


References

[1] Schwartz RA, Nervi SJ. Erythema nodosum: a sign of systemic disease. Am Fam Physician. 2007 Mar 1;75(5):695-700.

[2] Hafsi W, Badri T. Erythema Nodosum. [Updated 2022 Nov 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470369/

[3] García-Porrúa C, González-Gay MA, Vázquez-Caruncho M, López-Lazaro L, Lueiro M, Fernández ML, Alvarez-Ferreira J, Pujol RM. Erythema nodosum: etiologic and predictive factors in a defined population. Arthritis Rheum. 2000 Mar;43(3):584-92.

[4] Mert A, Kumbasar H, Ozaras R, Erten S, Tasli L, Tabak F, Ozturk R. Erythema nodosum: an evaluation of 100 cases. Clin Exp Rheumatol. 2007 Jul-Aug;25(4):563-70.

[5] Blake T, Manahan M, Rodins K. Erythema nodosum - a review of an uncommon panniculitis. Dermatol Online J. 2014 Apr 16;20(4):22376.

[6] [Clinical Dermatology 4.th Edition by Weller, Hunter, Savin and Dahl]

[7] Trapani S, Rubino C, Lodi L, Resti M, Indolfi G. Erythema Nodosum in Children: A Narrative Review and a Practical Approach. Children (Basel). 2022 Apr 4;9(4):511.

Scroll to top